IGSF8 抗体 (PE-Cy5)
Quick Overview for IGSF8 抗体 (PE-Cy5) (ABIN742407)
抗原
See all IGSF8 抗体适用
宿主
克隆类型
标记
应用范围
-
-
交叉反应
- 人, 小鼠
-
预测反应
- Rat,Cow,Pig,Horse
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from mouse IGSF8
-
亚型
- IgG
-
-
-
-
应用备注
-
FCM(1:100-500)
Optimal working dilution should be determined by the investigator. -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- IGSF8 (Immunoglobulin Superfamily, Member 8 (IGSF8))
-
别名
- IGSF8/CD316
-
背景
-
Synonyms: PGRL, EWI-2, KCT-4, ESTM34, R75384, AA033172, AU041109, Immunoglobulin superfamily member 8, IgSF8, CD81 partner 3, Glu-Trp-Ile EWI motif-containing protein 2, Keratinocyte-associated transmembrane protein 4, Prostaglandin regulatory-like protein, CD316, Ewi2, Kct4
Background: May play a key role in diverse functions ascribed to CD81 and CD9 such as oocytes fertilization or hepatitis C virus function. May regulate proliferation and differentiation of keratinocytes. May be a negative regulator of cell motility: suppresses T-cell mobility coordinately with CD81, associates with CD82 to suppress prostate cancer cell migration, regulates epidermoid cell reaggregation and motility on laminin-5 with CD9 and CD81 as key linkers. May also play a role on integrin-dependent morphology and motility functions. May participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain.
-
分子量
- 67kDa
-
基因ID
- 140559
-
UniProt
- Q8R366
抗原
-